Utilities Dividend & Income
SLNG Stabilis Solutions Inc
THO Thor Industries Inc
TME Tencent Music Entertainment Group
Go

Based in Canada

Pharmadrug Inc. is a Canada-based specialty pharmaceutical company, which is focused on the research, development and commercialization of controlled substances and medicines such as psychedelics, cannabis and naturally derived approved drugs. The Company operates through three divisions: Pharmadrug Production GmbH (Pharmadrug Production), Interrobang Ltd. (Interrobang), and Sairiyo Therapeutics Inc. (Sairiyo). Pharmadrug Production is a German medical cannabis distribution company, which imports and distributes Bedrocan cannabis from the Netherlands. Interrobang are licensed retailers in the Netherlands that are legally allowed to sell psilocybin bearing truffles. Interrobang is building a vertically integrated retail business with the goal to elevate the use of functional mushrooms, and psilocybin mushrooms. Sairiyo is a biotechnology company focused on repurposing and developing improved formulations of naturally derived compounds for serious, rare, and life-threatening diseases.

Closing Price: $0.0274

Day's Change: -0.0009 (-3.31%)

Bid: --

Ask: --

B/A Size: --

Day's High: 0.0288

Day's Low: 0.0274

Volume (Light) Volume: 65,211 10-day average volume: 97,982: 65,211

May 23, 2022
11:00 am ET	BioMed Stocks On the Move: GeoVax Labs, Nova Mentis, SIGA and PharmaDrug; Life Sciences Leaders Report Latest Advances in Antiviral Vaccines, and Novel Therapeutics for Oncology, Glaucoma and Autism EQNX::TICKER_START (NasdaqGM:SIGA),(Other OTC:NMLSF),(CNSX:NOVA.CN),(NASDAQ:GOVX),(Other OTC:LMLLF),(CNSX:PHRX.CN), EQNX::TICKER_END Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments...(Globe Newswire)
May 17, 2022
10:53 am ET	Healthcare Breakthroughs: IDRA, NMLSF, LMLLF, BBI; Life Sciences Leaders Report Latest Advances in Novel Therapeutics for Autism, Oncology, Autoimmune Diseases, and Glaucoma EQNX::TICKER_START (Other OTC:NMLSF),(CNSX:NOVA.CN),(NASDAQ:BBI),(NASDAQ:IDRA),(Other OTC:LMLLF),(CNSX:PHRX.CN), EQNX::TICKER_END Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and...(Globe Newswire)
May 13, 2022
10:08 am ET	BioMed Stocks On the Move: Nova Mentis, PolarityTE, Veru, and PharmaDrug; Life Sciences Leaders Report Latest Advances in Regenerative Tissue Technology, Novel Therapeutics for Oncology, COVID, Glaucoma, and Autism EQNX::TICKER_START (CNSX:NOVA.CN),(Other OTC:NMLSF),(NASDAQ:PTE),(NASDAQ:VERU),(Other OTC:LMLLF),(CNSX:PHRX.CN), EQNX::TICKER_END Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and...(Globe Newswire)
May 04, 2022
10:53 am ET	BioMed Momentum: NMLSF, BBI, LMLLF, VERU; Life Sciences Leaders Report Latest Advances in New Drug Development for Autism, COVID-19, Oncology, and Glaucoma EQNX::TICKER_START (Other OTC:NMLSF),(CNSX:NOVA.CN),(NASDAQ:VERU),(Other OTC:LMLLF),(CNSX:PHRX.CN),(NASDAQ:BBI), EQNX::TICKER_END Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and...(Globe Newswire)
May 03, 2022
8:02 am ET	Pharmadrug Advances Opthalmology Program with Final Selection of Lead DMT-Analogue to Provide Sustained Control of Elevated Intraocular Pressure for Glaucoma Toronto, Ontario--(Newsfile Corp. - May 3, 2022) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and...(Newsfile)
April 26, 2022
10:46 am ET	BioMed Momentum: AGRX, NMLSF, LMLLF, VERU; Life Sciences Leaders Report Latest Advances in New Drug Development for COVID-19, Oncology, Glaucoma, and Autism Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO's of: Veru Inc. (NASDAQ: VERU), Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), Agile Therapeutics (NASDAQ...(Globe Newswire)
April 25, 2022
9:24 am ET	Next Super Stocks on the Move: NEXCF, NMLSF, OGGFF, LMLLF; Driving Disruptive Innovation with Explosive Revenue Growth Potential in Biopharma, E-Commerce, Metaverse, and Plant-Based Brands Wall Street Reporter, the trusted name in financial news since 1843, is highlighting the latest CEO comments and news from companies recently presenting at its highly acclaimed NEXT SUPER STOCK investor conferences, and online events which engage...(Globe Newswire)
April 19, 2022
9:53 am ET	Healthcare Breakthroughs: AGRX, NMLSF, BBI, LMLLF; BioMed Leaders Report Latest Advances in New Drug Development for Women's Health, Autism, Glaucoma, and Cancer Therapeutics Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO's of: Brickell Biotech (NASDAQ: BBI), Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), Agile Therapeutics...(Globe Newswire)
7:32 am ET	PharmaDrug Advances Oncology Program with Filing of Provisional Patent Following Positive Findings for the Combination of PD-001 and Frontline Chemotherapy in Prostate Cancer Study Toronto, Ontario--(Newsfile Corp. - April 19, 2022) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances...(Newsfile)
April 14, 2022
9:57 am ET	BioMed Momentum: VERU, NMLSF, PHRX, CRXT; Life Sciences Leaders Report Latest Advances in New Drug Development for COVID-19, Cancers, Glaucoma, and Autism Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEOs of: Veru Inc. (NASDAQ: VERU), Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), Clarus Therapeutics (NASDAQ...(Globe Newswire)
April 12, 2022
8:58 am ET	BioMed Stocks On the Move: Nova Mentis, PolarityTE, Biodesix and PharmaDrug; Life Sciences Leaders Report Latest Advances in Regenerative Tissue Technology, New Drugs for Cancers, Glaucoma, and Autism, and Diagnostics. Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO's of: PolarityTE, Inc. (NASDAQ: PTE) Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), Biodesix, Inc. (NASDAQ...(Globe Newswire)
April 11, 2022
10:41 am ET	Healthcare Breakthroughs: Veru, Nova Mentis, Phio, and PharmaDrug; Visionary CEOs Report Latest Advances in New Drug Development for COVID-19, Cancers, Glaucoma, and Autism Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO's of: Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), Phio Pharmaceuticals (NASDAQ: PHIO), Veru Inc...(Globe Newswire)
April 08, 2022
9:44 am ET	BioMed Leaders: Sunshine Biopharma, PharmaDrug, Blue Water Vaccines, and MedAvail; Visionary CEOs Advancing Healthcare, with Vaccines, Cancer Therapeutics, and Affordable Pharmaceuticals Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEOs of: Sunshine Biopharma, Inc. (NASDAQ: SBFM), PharmaDrug (OTC: LMLLF) (CSE: PHRX), Blue Water Vaccines (NASDAQ...(Globe Newswire)
April 07, 2022
7:31 am ET	PharmaDrug Advances DMT-Analogue Program for Glaucoma with Production of Medical Device Designed to Provide Sustained Control of Elevated Intraocular Pressure Toronto, Ontario--(Newsfile Corp. - April 7, 2022) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances...(Newsfile)
April 04, 2022
10:29 am ET	Leaders: ChargePoint, PharmaDrug, DeepMarkit, and DraftKings; Visionary CEOs Highlight New Trends in Electric Vehicles, Biotech, Carbon Credits, NFTs and Sports Betting Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEOs of: ChargePoint Holdings, Inc. (NYSE: CHPT), PharmaDrug (OTC: LMLLF) (CSE: PHRX) DeepMarkit (OTC: MKTDF)...(Globe Newswire)
April 01, 2022
8:23 am ET	Pharmadrug Advances PD-001, Its Patented, Improved Version of Cepharanthine for Oncology and Infectious Disease Toronto, Ontario--(Newsfile Corp. - April 1, 2022) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances...(Newsfile)
March 31, 2022
10:33 am ET	Megatrends: CEOs of NIO, PharmaDrug, SoFi, and NuRAN Advancing New Growth Opportunities in Electric Vehicles, Biotech, Mobile, and Fintech Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEOs of: NIO, Inc. (NYSE:NIO), PharmaDrug (OTC: LMLLF) (CSE: PHRX), NuRAN Wireless (OTC: NRRWF) (CSE: NUR) and SoFi...(Globe Newswire)
9:00 am ET	Leaders: Moderna, Tilray, PharmaDrug, and Vinco; Visionary CEO Highlight New Trends in Vaccines, Biotech, Digital Media, and Consumer Brands Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO's of: Moderna, Inc. (NASDAQ: MRNA), PharmaDrug (OTC: LMLLF) (CSE: PHRX) Tilray, Inc. (NASDAQ:TLRY) and Vinco...(Globe Newswire)
March 09, 2022
7:31 am ET	PharmaDrug Announces Interim Positive Findings for the Combination of Cepharanthine and Frontline Chemotherapy for IND-Enabling Prostate Cancer Study Toronto, Ontario--(Newsfile Corp. - March 9, 2022) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances...(Newsfile)

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for varies.

Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and